source
- Caldera and Vidya secure $478M via reverse mergers to go publicCaldera Therapeutics, a U.S. bispecific antibody biotech, announced a reverse merger with Nasdaq-listed Synlogic to become a public company. The deal includes a $278 million private placement from…
- Kyverna partners with ElevateBio to supply its autologous CAR-T therapy for autoimmune launchesKyverna Therapeutics has signed a five‑year manufacturing agreement with contract development and manufacturing organization ElevateBio. The deal makes ElevateBio the primary supplier of Kyverna's…